ArticleFrontiers in physiology2026
An ensemble machine learning model based on magnetic resonance imaging features for diagnosing deep infiltrating endometriosis.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Radiomics and Artificial Intelligence in Ovarian Endometriosis Imaging: A Systematic Review and Critical Appraisal of Emerging Evidence.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To address the need for more objective and reproducible preoperative diagnosis of deep infiltrating endometriosis (DIE), this study aimed to develop and validate a weighted ensemble machine learning (ML) model using multimodal magnetic resonance imaging (MRI) and clinical features, and to compare its performance against radiologists. Methods: This retrospective study enrolled 330 patients (168 in DIE group, 162 in control group) who underwent MRI examinations and surgical-pathological confirmation during January 2020 to June 2025. Following feature selection, five ML models were constructed: logistic regression (LR), support vector machine (SVM), random forest (RF), XGBoost, and CatBoost. A weighted ensemble model was developed via soft voting, weighting each model's prediction by its AUC on validation set. Model performance and clinical net benefit were assessed using ROC curves, calibration curves, and decision curve analysis. Model interpretability was achieved using a weighted SHapley additive exPlanations (SHAP) method. The ensemble model's performance was compared to two radiologists' independent readings. Results: The ensemble model demonstrated superior performance on the independent test set, achieving an AUC of 0.938 (95% CI: 0.883-0.979; sensitivity, 0.920; accuracy, 0.859), outperforming all individual models. Weighted SHAP analysis identified C-reactive protein, cancer antigen 125, T2-weighted signal intensity, and symptom duration as top contributors. The radiologists' average AUC was 0.818 (κ = 0.42), whereas the ensemble model achieved a higher AUC on the same dataset (P = 0.002). With AI assistance, the radiologists' accuracy increased to 0.920 and interpretation time decreased by approximately 30%. Conclusion: The weighted ensemble ML model, integrating multimodal MRI and clinical features, enables high-accuracy DIE identification with favorable stability and interpretability. This model holds significant potential as an effective clinical decision-support tool for radiologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.